New Rapid Salmonella Test Improves Food Safety
News Oct 10, 2017 | Original Story by Joe Schwartz for Cornell University
A new test allows accurate, rapid testing for Salmonella bacteria, one of the leading causes of food-borne illness across all regions of the world. Salmonella can infect animals as well as people, with commonly reported cases of people falling sick after handling pets and livestock.
Tests that used to take days now take 24 hours, with a hundredfold improvement in detection for at least one type of Salmonella – called Salmonella Dublin – that is an emerging concern and is difficult to grow in culture, making diagnosis difficult.
The new method, first developed for automated food safety testing and then adapted by Cornell scientists for a wider range of sample types, can detect the bacteria from environmental and clinical samples, including swabs, feces, milk and blood.
The test improves diagnosis time from as many as five days using current procedures, according to a recent study published Sept. 1 in the Journal of Veterinary Diagnostic Investigation.
“Because we have this 24-hour turnaround time with the new test, there are veterinary hospitals and clinics that can test and get results rapidly and make sure they are not exposing other animals to Salmonella,” said Belinda Thompson, assistant clinical professor at the Animal Health Diagnostic Center and a senior author of the paper.
Fast clinical diagnoses also allow veterinarians to quickly quarantine an infected animal.
Salmonella Dublin is “host adapted” in cattle, meaning infected animals can become permanent or long-term carriers, putting herd mates, especially susceptible calves, at risk. This strain can infect people who may be exposed by contact with infected animals, by drinking raw milk, or by consuming other contaminated food products. In humans, Salmonella Dublin has higher hospitalization and fatality rates than other Salmonella types; it causes systemic infection of body tissues, similar to typhoid.
“Salmonella biosurveillance in veterinary facilities is critical because animals can shed the bacteria without showing clinical disease signs,” said Laura Goodman, a senior research associate in the Department of Population Medicine and Diagnostic Sciences and lead author of the study. Goodman added that the method described in the study is now available as an environmental testing program through the Animal Health Diagnostic Center.
This article has been republished from materials provided by Cornell University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Laura B. Goodman, Patrick L. McDonough, Renee R. Anderson, Rebecca J. Franklin-Guild, James R. Ryan, Gillian A. Perkins, Anil J. Thachil, Amy L. Glaser, Belinda S. Thompson. Detection of Salmonella spp. in veterinary samples by combining selective enrichment and real-time PCR. J Vet Diagn Invest. 2017 Aug 1:1040638717728315. doi: 10.1177/1040638717728315.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.